Remepy Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 80

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $36M

  • Investors
  • 17

Remepy General Information

Description

Developer of a digital healthcare platform designed to facilitate the creation of hybrid drugs. The company uses AI-driven digital protocols and mobile applications to combine traditional pharmaceuticals with personalized behavioral and cognitive interventions, enabling pharmaceutical companies to enhance drug efficacy and improve patient outcomes through clinically validated neuro-endocrine and neuro-immunological modulation.

Contact Information

Website
www.remepy.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • New York, NY
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Digital Health, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • New York, NY
  • United States

Remepy Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Remepy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 12-Aug-2026 $36M Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Seed Round 01-May-2024 $10M $12.5M Completed Generating Revenue
1. Seed Round 01-Dec-2022 $2.5M $2.5M Completed Generating Revenue
To view Remepy’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Remepy Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital healthcare platform designed to facilitate the creation of hybrid drugs. The company uses AI-driv
Other Pharmaceuticals and Biotechnology
New York, NY
80 As of 2026

New York, NY
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Remepy Competitors (6)

One of Remepy’s 6 competitors is Click Therapeutics, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Click Therapeutics Venture Capital-Backed New York, NY
Big Health Venture Capital-Backed San Francisco, CA
Noom Venture Capital-Backed Princeton, NJ
Hinge Health Formerly VC-backed San Francisco, CA
Omada Formerly VC-backed Dallas, TX
To view Remepy’s complete competitors history, request access »

Remepy Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Remepy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260229336-A1 Digital therapeutics and combination therapy for enhancing fertility Pending 15-Jan-2025
WO-2026154475-A1 Digital therapeutics and combination therapy for enhancing fertility Pending 15-Jan-2025
US-20260142007-A1 Digital therapeutics and combination therapy for the treatment of tenosynovial giant cell tumor (tgct) Pending 19-Nov-2024
WO-2026110145-A1 Digital therapeutics and combination therapy for the treatment of tenosynovial giant cell tumor (tgct) Pending 19-Nov-2024
WO-2026099869-A1 Digital therapeutics and combination therapy for the treatment of parkinson's disease Pending 11-Nov-2024 A61P25/16
To view Remepy’s complete patent history, request access »

Remepy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Remepy Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
IT-Farm Venture Capital Minority
Key1 Capital Growth/Expansion Minority
M Ventures Corporate Venture Capital Minority
O.G. Venture Partners Venture Capital Minority
Qumra Capital Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

Remepy FAQs

  • When was Remepy founded?

    Remepy was founded in 2021.

  • Where is Remepy headquartered?

    Remepy is headquartered in New York, NY.

  • What is the size of Remepy?

    Remepy has 80 total employees.

  • What industry is Remepy in?

    Remepy’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Remepy a private or public company?

    Remepy is a Private company.

  • What is Remepy’s current revenue?

    The current revenue for Remepy is .

  • How much funding has Remepy raised over time?

    Remepy has raised $62M.

  • Who are Remepy’s investors?

    IT-Farm, Key1 Capital, M Ventures, O.G. Venture Partners, and Qumra Capital are 5 of 17 investors who have invested in Remepy.

  • Who are Remepy’s competitors?

    Click Therapeutics, Big Health, Noom, Hinge Health, and Omada are some of the 6 competitors of Remepy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process